Clinical Trial Management System Capability Analysis
Jump to navigation
Jump to search
A Clinical Trial Management System Capability Analysis is a System Capability Analysis for a CTMS.
References
2018
- (Fogel, 2018) ⇒ David B. Fogel. (2018). “Factors Associated with Clinical Trials That Fail and Opportunities for Improving the Likelihood of Success: A Review.” In: Contemporary Clinical Trials Communications, 11.
| Factor | Opportunity | Role for Artificial Intelligence |
|---|---|---|
| Poor study design | More complete literature review | |
| Appropriate endpoints | ||
| Inappropriate eligibility criteria | ||
| Appropriate statistical analysis | ||
| Determination of appropriate sample size | ||
| Reducing likelihood of amendments | ||
| Inconsistencies in protocol | ||
| Ineffective site selection | ||
| Poor recruitment | Improved use of funds | |
| Ensuring appropriate eligibility criteria | ||
| Facilitating locating eligible patients | ||
| Enrolling patients who are likely to complete the trial | ||
| Patient burden/safety | ||
| Minimize out-of-pocket expenses | ||
| Minimize possibility of contraindicated medicines/procedures | ||
| Increase likelihood of feeling respected | ||
| Poor trial execution | ||
| Preparing data and reporting for write-up | ||
| Lack of general awareness | ||
| Overall | Factor analysis to improve trade-offs based on budget and other constraints |